Latem1(IMPC)Ics/Latem1(IMPC)Ics
C57BL/6N-Latem1(IMPC)Ics/Ics
|
abnormal startle reflex |
J:211773
|
abnormal vitreous body morphology |
J:211773
|
increased circulating bilirubin level |
J:211773
|
Lattm1.1Mal/Lattm1.1Mal
involves: 129S2/SvPas
|
abnormal B cell activation |
J:77098
|
abnormal gamma-delta T cell differentiation |
J:77098
|
abnormal immune serum protein physiology |
J:77098
|
abnormal immune system organ morphology |
J:77098
|
abnormal lymph node germinal center morphology |
J:125722
|
abnormal lymph node secondary follicle morphology |
J:125722
|
abnormal lymphocyte morphology |
J:77098
|
abnormal salivary gland morphology |
J:262891
|
abnormal spleen periarteriolar lymphoid sheath morphology |
J:125722
|
abnormal T cell selection |
J:77098
|
abnormal T cell subpopulation ratio |
J:77098
|
abnormal T-helper 2 physiology |
J:125722
|
albuminuria |
J:125722
|
chronic inflammation |
J:77098
|
decreased body weight |
J:262891
|
decreased double-positive T cell number |
J:77098
|
enlarged lymph nodes |
J:77098
|
enlarged spleen |
J:77098
|
glomerulonephritis |
J:125722
|
increased anti-chromatin antibody level |
J:125722
|
increased anti-erythrocyte antigen antibody level |
J:125722
|
increased anti-nuclear antigen antibody level |
J:125722
|
increased B cell number |
J:77098
|
increased blood urea nitrogen level |
J:125722
|
increased CD4-positive, alpha-beta T cell number |
J:77098,
J:125722
|
increased eosinophil cell number |
J:77098
|
increased IgE level |
J:77098,
J:125722
|
increased IgG1 level |
J:77098,
J:125722,
J:262891
|
increased IgM level |
J:125722
|
increased inflammatory response |
J:262891
|
increased interferon-gamma secretion |
J:77098
|
increased interleukin-4 secretion |
J:77098
|
increased memory T cell number |
J:77098
|
increased plasma cell number |
J:125722
|
increased spleen germinal center number |
J:125722
|
increased spleen weight |
J:262891
|
increased susceptibility to autoimmune hemolytic anemia |
J:125722
|
increased T cell proliferation |
J:77098
|
increased T-helper 2 cell number |
J:77098
|
kidney inflammation |
J:262891
|
liver inflammation |
J:125722
|
lung inflammation |
J:125722
|
pancreas fibrosis |
J:262891
|
pancreas inflammation |
J:262891
|
phlebitis |
J:262891
|
renal fibrosis |
J:262891
|
renal glomerular immunoglobulin deposits |
J:125722
|
salivary gland inflammation |
J:262891
|
spleen hyperplasia |
J:77098
|
thymus hypoplasia |
J:77098
|
Lattm1.1Mal/Lattm1.1Mal
involves: 129S2/SvPas * C57BL/6
|
abnormal T cell proliferation |
J:131351
|
abnormal T-helper 2 physiology |
J:131351
|
Lattm1Bpay/Lattm1Bpay
involves: 129S2/SvPas
|
abnormal platelet aggregation |
J:103904
|
abnormal T cell differentiation |
J:103904
|
arrested T cell differentiation |
J:103904
|
decreased double-negative T cell number |
J:103904
|
decreased T cell number |
J:103904
|
decreased thymocyte number |
J:103904
|
normal
immune system phenotype |
J:103904
|
small thymus |
J:103904
|
Lattm1Les/Lattm1.1Wz
involves: C57BL/6
|
abnormal effector T cell morphology |
J:147946
|
Lattm1Les/Lattm1.1Wz Tg(Cd4-cre)1Cwi/0
involves: C57BL/6 * DBA/2
|
abnormal effector T cell morphology |
J:147946
|
abnormal T cell differentiation |
J:147946
|
abnormal T cell physiology |
J:147946
|
decreased CD4-positive, alpha-beta T cell number |
J:147946
|
decreased CD8-positive, alpha-beta T cell number |
J:147946
|
decreased regulatory T cell number |
J:147946
|
decreased thymocyte number |
J:147946
|
increased double-positive T cell number |
J:147946
|
increased gamma-delta T cell number |
J:147946
|
small thymus |
J:147946
|
Lattm1Les/Lattm1.2Wz
involves: C57BL/6 * FVB/N
|
absent T cells |
J:147946
|
arrested T cell differentiation |
J:147946
|
Lattm1Les/Lattm1Les
Not Specified
|
abnormal T cell morphology |
J:54059
|
arrested T cell differentiation |
J:54059,
J:116964
|
decreased double-negative T cell number |
J:54059
|
decreased T cell number |
J:54059
|
decreased thymocyte number |
J:54059
|
small thymus |
J:54059
|
Lattm2.1Lov/Lattm2.1Lov
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N
|
abnormal T cell differentiation |
J:77695
|
decreased T cell number |
J:77695
|
small thymus |
J:77695
|
Lattm2.1Mal/Lattm2.1Mal
involves: 129S2/SvPas
|
abnormal B cell activation |
J:94074
|
abnormal B cell differentiation |
J:94074
|
abnormal gamma-delta T cell differentiation |
J:94074
|
abnormal immune system organ morphology |
J:94074
|
abnormal lymphocyte morphology |
J:94074
|
abnormal lymphopoiesis |
J:94074
|
abnormal mature gamma-delta T cell morphology |
J:94074
|
abnormal plasma cell morphology |
J:94074
|
abnormal spleen morphology |
J:94074
|
abnormal spleen periarteriolar lymphoid sheath morphology |
J:94074
|
abnormal spleen white pulp morphology |
J:94074
|
abnormal T cell activation |
J:94074
|
abnormal T-helper 2 cell morphology |
J:94074
|
abnormal thymocyte activation |
J:94074
|
absent CD4-positive, alpha-beta T cells |
J:94074
|
absent CD8-positive, alpha-beta T cells |
J:94074
|
arrested T cell differentiation |
J:94074
|
decreased double-positive T cell number |
J:94074
|
enlarged lymph nodes |
J:94074
|
enlarged spleen |
J:94074
|
increased B cell number |
J:94074
|
increased IgE level |
J:94074
|
increased IgG1 level |
J:94074
|
increased immunoglobulin level |
J:94074
|
increased interleukin-4 secretion |
J:94074
|
increased mature gamma-delta T cell number |
J:94074
|
premature death |
J:94074
|
thymus hypoplasia |
J:94074
|
Lattm3.1Mal/Lattm3.1Mal
involves: 129S2/SvPas
|
abnormal gamma-delta T cell differentiation |
J:94074
|
abnormal lymph node cell ratio |
J:94074
|
abnormal splenic cell ratio |
J:94074
|
abnormal thymocyte activation |
J:94074
|
abnormal thymus cell ratio |
J:94074
|
absent CD4-positive, alpha-beta T cells |
J:94074
|
absent CD8-positive, alpha-beta T cells |
J:94074
|
absent mature gamma-delta T cells |
J:94074
|
arrested T cell differentiation |
J:94074
|
decreased double-positive T cell number |
J:94074
|
decreased T cell number |
J:94074
|
increased T cell number |
J:94074
|
Lattm4.1Mal/Lattm4.1Mal
involves: 129P2/OlaHsd
|
abnormal gamma-delta T cell differentiation |
J:94074
|
abnormal lymph node cell ratio |
J:94074
|
abnormal lymphocyte morphology |
J:94074
|
abnormal splenic cell ratio |
J:94074
|
abnormal thrombosis |
J:125744
|
abnormal thymocyte activation |
J:94074
|
abnormal thymus cell ratio |
J:94074
|
absent CD4-positive, alpha-beta T cells |
J:94074
|
absent CD8-positive, alpha-beta T cells |
J:94074
|
absent mature gamma-delta T cells |
J:94074
|
arrested T cell differentiation |
J:94074
|
decreased double-positive T cell number |
J:94074
|
decreased platelet aggregation |
J:125744
|
decreased T cell number |
J:94074
|
Lattm5.1Mal/Lattm5.1Mal
involves: C57BL/6
|
arrested T cell differentiation |
J:152363
|
Lattm9Mal/Lattm9Mal
involves: C57BL/6
|
abnormal B cell number |
J:205441
|
abnormal immune system morphology |
J:205441
|
abnormal immune system physiology |
J:205441
|
abnormal lymphopoiesis |
J:205441
|
increased T-helper 2 cell number |
J:205441
|